Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Camptothecin
Potential treatment - theoretical effect Natural product Antiviral Jan/31/2022
10-hydroxyusambarensine
Potential treatment - theoretical effect Natural product Antiviral Sep/02/2021
rlcv-miR-rL1-28-3p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
aly-miR396a-5p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
Naphthazarin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021
Anacardic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Sciadopitysin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgo biloba leaves extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgolic acid C17:1
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ambroxol
Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021
Reduning
Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021
Baicalein
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Baicalin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Sargassum horneri polysaccharide extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021
L-Carnitine
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/14/2021
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Soybean Trypsin Inhibitor
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Trichostatin A
Potential treatment - theoretical effect Natural product Antiviral Apr/10/2021
(-)-Gallocatechin gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/09/2021
Epigallocatechin Gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021